OAKLANDS HEALTH CENTRE — All Prescriptions & Medications — Page 13
Practice Code: G82160 | HYTHE, CT21 6BD
Showing results 601-650 of 675
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Magnesium glycerophosphate | 14 | 1,400 | £606 | +1.9% vs avg |
| Other compound vitamin/mineral formulation preparations | 14 | 856 | £83 | -56.3% ▼ |
| Ciprofloxacin | 14 | 210 | £80 | +51.9% ▲ |
| Pimecrolimus | 14 | 510 | £314 | -17.3% ▼ |
| 14 | 33 | £37 | -55.0% ▼ | |
| 14 | 510 | £2.2K | +65.9% ▲ | |
| Torasemide | 13 | 420 | £175 | +15.8% ▲ |
| Naftidrofuryl oxalate | 13 | 1,092 | £115 | -60.1% ▼ |
| Prasugrel | 13 | 560 | £75 | -58.6% ▼ |
| Buspirone hydrochloride | 13 | 736 | £89 | -74.2% ▼ |
| Tapentadol | 13 | 728 | £972 | -68.4% ▼ |
| Vigabatrin | 13 | 1,396 | £688 | +19.5% ▲ |
| Rifaximin | 13 | 693 | £3.1K | -51.6% ▼ |
| Fusidic acid | 13 | 70 | £277 | +25.8% ▲ |
| Timolol and brimonidine | 13 | 130 | £288 | -7.4% ▼ |
| Hydrocortisone acetate | 13 | 130 | £411 | +96.7% ▲ |
| 13 | 54 | £419 | -53.3% ▼ | |
| 13 | 23 | £1.5K | +53.2% ▲ | |
| 13 | 720 | £2.0K | +10.4% ▲ | |
| 13 | 490 | £700 | +41.2% ▲ | |
| Sucralfate | 12 | 1,440 | £2.0K | +42.9% ▲ |
| Finerenone | 12 | 336 | £418 | +10.3% ▲ |
| Propafenone hydrochloride | 12 | 672 | £64 | +10.8% ▲ |
| Chloral hydrate | 12 | 1,800 | £2.9K | +18.5% ▲ |
| Chlorpromazine hydrochloride | 12 | 336 | £204 | -69.5% ▼ |
| Guanfacine | 12 | 336 | £868 | -53.3% ▼ |
| Famciclovir | 12 | 529 | £4.9K | +155.3% ▲ |
| Mebendazole | 12 | 216 | £17 | +4.8% ▲ |
| Exenatide | 12 | 48 | £880 | -31.6% ▼ |
| Denosumab | 12 | 12 | £2.1K | -55.9% ▼ |
| Etonogestrel | 12 | 12 | £1.0K | -58.5% ▼ |
| Sevelamer | 12 | 1,872 | £294 | -45.2% ▼ |
| Powder 1.4 - 1.6 kcal/ml milkshake with fibre (0913011) | 12 | 336 | £269 | +47.0% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914011) | 12 | 246.0K | £4.4K | +3.8% ▲ |
| Hydrocort sodiumphos | 12 | 450 | £157 | +56.8% ▲ |
| 12 | 530 | £50 | +0.7% vs avg | |
| 12 | 114 | £263 | -53.7% ▼ | |
| 12 | 210 | £472 | -72.7% ▼ | |
| 12 | 720 | £2.3K | +14.4% ▲ | |
| Nizatidine | 11 | 330 | £756 | -68.0% ▼ |
| Eprosartan | 11 | 308 | £150 | -45.5% ▼ |
| Lofepramine hydrochloride | 11 | 350 | £157 | -63.2% ▼ |
| Aspirin | 11 | 268 | £26 | +11.9% ▲ |
| Rimegepant | 11 | 72 | £929 | +12.1% ▲ |
| Stiripentol | 11 | 1,320 | £6.2K | -8.3% ▼ |
| Propylthiouracil | 11 | 1,932 | £188 | -12.5% ▼ |
| Somatropin | 11 | 28 | £9.5K | -22.4% ▼ |
| Fesoterodine fumarate | 11 | 728 | £62 | -72.1% ▼ |
| Degarelix | 11 | 12 | £1.4K | -36.6% ▼ |
| Ketorolac trometamol | 11 | 95 | £73 | +18.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.